Daniel Dines - 27 Oct 2025 Form 4 Insider Report for UiPath, Inc. (PATH)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
29 Oct 2025, 16:39:19 UTC
Prior SEC filing
24 Oct 2025
Next SEC filing
30 Oct 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Brad Brubaker, Attorney-in-Fact

Key filing fact

Daniel Dines filed Form 4 for UiPath, Inc. (PATH) on 29 Oct 2025.

Key facts

  • This page summarizes Daniel Dines's Form 4 filing for UiPath, Inc. (PATH).
  • 3 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 29 Oct 2025, 16:39.

Change

  • Previous filing in this sequence was filed on 24 Oct 2025.
  • Current net transaction value: -$2,257,947.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001855767 Primary reporting owner

Dines Daniel

Relationship
CEO and Chairman, Director, 10%+ Owner
Address
C/O UIPATH, INC., ONE VANDERBILT AVENUE, 60TH FLOOR, NEW YORK
Signature
/s/ Brad Brubaker, Attorney-in-Fact
Signature date
29 Oct 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PATH transaction

Class A Common Stock

Sale

Transaction value
$752,670
Shares
-45,000
Change %
-0.15%
Price
$16.73
Shares after
29,603,585
Date
27 Oct 2025
Ownership
Direct
Footnotes
F1, F2
PATH transaction

Class A Commmon Stock

Sale

Transaction value
$772,344
Shares
-45,000
Change %
-0.15%
Price
$17.16
Shares after
29,558,585
Date
28 Oct 2025
Ownership
Direct
Footnotes
F1, F3
PATH transaction

Class A Commmon Stock

Sale

Transaction value
$732,933
Shares
-45,000
Change %
-0.15%
Price
$16.29
Shares after
29,513,585
Date
29 Oct 2025
Ownership
Direct
Footnotes
F1, F4, F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 5 footnotes

Footnote F1

These shares were sold in compliance with a qualified selling plan adopted by the Reporting Person pursuant to Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended.

Footnote F2

The range of prices for the transactions reported was from $16.5500 to $16.9500. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.

Footnote F3

The range of prices for the transactions reported was from $17.0700 to $17.3600. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.

Footnote F4

The range of prices for the transactions reported was from $16.1700 to $16.4400. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.

Footnote F5

The reporting person no longer has a reportable beneficial interest in 240,000 shares of Class A Common Stock included in the prior ownership reports of the reporting person.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .